Romidepsin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Romidepsin. Educational only — not medical advice.
Labeled uses
Romidepsin for injection is indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in adult patients who have received at least one prior systemic therapy.
Source: FDA labeling via NIH DailyMed (set 73a2028d…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.